Practical guidelines for the treatment of cholera
- PMID: 8736618
- DOI: 10.2165/00003495-199651060-00005
Practical guidelines for the treatment of cholera
Abstract
Cholera is a dramatic clinical illness that requires rapid diagnosis and aggressive therapy. Clinical signs and symptoms of mild, moderate and severe dehydration must be determined, before beginning fluid therapy. Fluid therapy has 2 phases: rehydration (first 3 to 4 hours to correct deficits) and maintenance (to match continuing losses). The route and speed of fluid administration will depend on the degree of dehydration. Patients with severe dehydration should be treated intravenously, as should those patients who do not tolerate oral rehydration solution (ORS). Ringer's lactate is the preferred intravenous solution, although normal saline may be used along with ORS. For most patients with cholera, an ORS using one of the higher sodium-containing solutions and plain water optimally provide the fluid and salt needed. Close monitoring of intake, outputs and hydration status should be performed for all patients. Antimicrobial therapy should be given to moderately and severely ill patients in order to decrease the volume of fluids lost and to shorten the period of excretion of vibrios.
Similar articles
-
An evaluation of current cholera treatment.Expert Opin Pharmacother. 2003 Feb;4(2):141-6. doi: 10.1517/14656566.4.2.141. Expert Opin Pharmacother. 2003. PMID: 12562304 Review.
-
Standard WHO-ORS versus reduced-osmolarity ORS in the management of cholera patients.J Health Popul Nutr. 2006 Mar;24(1):107-12. J Health Popul Nutr. 2006. PMID: 16796157 Clinical Trial.
-
Citrate can effectively replace bicarbonate in oral rehydration salts for cholera and infantile diarrhoea.Bull World Health Organ. 1986;64(1):145-50. Bull World Health Organ. 1986. PMID: 3015443 Free PMC article. Clinical Trial.
-
Treatment of severe cholera: a review of strategies to reduce stool output and volumes of rehydration fluid.Trans R Soc Trop Med Hyg. 2017 May 1;111(5):204-210. doi: 10.1093/trstmh/trx041. Trans R Soc Trop Med Hyg. 2017. PMID: 28957470 Review.
-
[Rapid intravenous rehydration in acute diarrhea].Bol Med Hosp Infant Mex. 1992 Aug;49(8):506-13. Bol Med Hosp Infant Mex. 1992. PMID: 1449637 Spanish.
Cited by
-
Tetracyclines and bone: Unclear actions with potentially lasting effects.Bone. 2022 Jun;159:116377. doi: 10.1016/j.bone.2022.116377. Epub 2022 Mar 3. Bone. 2022. PMID: 35248788 Free PMC article. Review.
-
Severe acute diarrhea.Gastroenterol Clin North Am. 2003 Dec;32(4):1249-67. doi: 10.1016/s0889-8553(03)00100-6. Gastroenterol Clin North Am. 2003. PMID: 14696306 Free PMC article. Review.
-
Identification of Widespread Antibiotic Exposure in Patients With Cholera Correlates With Clinically Relevant Microbiota Changes.J Infect Dis. 2019 Oct 8;220(10):1655-1666. doi: 10.1093/infdis/jiz299. J Infect Dis. 2019. PMID: 31192364 Free PMC article.
-
Bovine Lactoferrin and Lactoferrin-Derived Peptides Inhibit the Growth of Vibrio cholerae and Other Vibrio species.Front Microbiol. 2018 Jan 11;8:2633. doi: 10.3389/fmicb.2017.02633. eCollection 2017. Front Microbiol. 2018. PMID: 29375503 Free PMC article.
-
Antimicrobial drugs for treating cholera.Cochrane Database Syst Rev. 2014 Jun 19;2014(6):CD008625. doi: 10.1002/14651858.CD008625.pub2. Cochrane Database Syst Rev. 2014. PMID: 24944120 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical